Market revenue in 2023 | USD 2,758.5 million |
Market revenue in 2030 | USD 7,422.4 million |
Growth rate | 15.2% (CAGR from 2023 to 2030) |
Largest segment | Blood transfusion |
Fastest growing segment | Pharmacotherapy |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bone Marrow Transplant, Blood Transfusion, Pharmacotherapy |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sickle cell disease treatment market will help companies and investors design strategic landscapes.
Blood transfusion was the largest segment with a revenue share of 48.45% in 2023. Horizon Databook has segmented the Global sickle cell disease treatment market based on bone marrow transplant, blood transfusion, pharmacotherapy covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of global-level data and insights on the Global sickle cell disease treatment market , including forecasts for subscribers. This global databook contains high-level insights into Global sickle cell disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account